Canada markets close in 34 minutes

Khiron Life Sciences Corp. (KHRN.V)

TSXV - TSXV Real Time Price. Currency in CAD
Add to watchlist
0.3900+0.0100 (+2.63%)
As of 3:07PM EST. Market open.
Currency in CAD

Valuation Measures

Market Cap (intraday) 558.57M
Enterprise Value 345.26M
Trailing P/E N/A
Forward P/E 1-3.25
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)7.31
Price/Book (mrq)0.90
Enterprise Value/Revenue 35.65
Enterprise Value/EBITDA 6-1.46

Trading Information

Stock Price History

Beta (5Y Monthly) 1.92
52-Week Change 3-65.45%
S&P500 52-Week Change 314.36%
52 Week High 31.1200
52 Week Low 30.3000
50-Day Moving Average 30.3762
200-Day Moving Average 30.4477

Share Statistics

Avg Vol (3 month) 3708.62k
Avg Vol (10 day) 3751.93k
Shares Outstanding 5150.17M
Float 127.18M
% Held by Insiders 111.88%
% Held by Institutions 11.25%
Shares Short (Dec. 30, 2020) 4166.93k
Short Ratio (Dec. 30, 2020) 40.21
Short % of Float (Dec. 30, 2020) 4N/A
Short % of Shares Outstanding (Dec. 30, 2020) 40.11%
Shares Short (prior month Nov. 29, 2020) 41.36M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:8
Last Split Date 3May 23, 2018

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec. 30, 2019
Most Recent Quarter (mrq)Sep. 29, 2020


Profit Margin 0.00%
Operating Margin (ttm)-388.74%

Management Effectiveness

Return on Assets (ttm)-25.05%
Return on Equity (ttm)-44.71%

Income Statement

Revenue (ttm)8.01M
Revenue Per Share (ttm)0.07
Quarterly Revenue Growth (yoy)-30.50%
Gross Profit (ttm)2.44M
EBITDA -31.09M
Net Income Avi to Common (ttm)-29.9M
Diluted EPS (ttm)-0.2630
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)14.62M
Total Cash Per Share (mrq)0.1
Total Debt (mrq)2.82M
Total Debt/Equity (mrq)5.51
Current Ratio (mrq)3.49
Book Value Per Share (mrq)0.43

Cash Flow Statement

Operating Cash Flow (ttm)-27.29M
Levered Free Cash Flow (ttm)-21.53M